Identification and characterization of glycoproteins on the spore surface of Clostridium difficile

Journal of Bacteriology

Volumn 196, Issue 14, 2014, Pages 2627-2637

  Strong, Philippa C R ^a   Fulton, Kelly M ^a   Aubry, Annie ^a   Foote, Simon ^a   Twine, Susan M ^a   Logan, Susan M ^a  

^a NATIONAL RESEARCH COUNCIL CANADA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; BACTERIAL PROTEIN; BACTERIUM ANTIBODY; BCLA1 PROTEIN; BCLA2 PROTEIN; BCLA3 PROTEIN; BCLB PROTEIN; BETA O GLCNAC ANTIBODY; GLYCOPROTEIN; GLYCOSYLTRANSFERASE; HEXOSAMINE; LYSOZYME; MEMBRANE PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; BACTERIAL GENE; BACTERIAL SPORE; BACTERIAL STRAIN; BACTERIUM MUTANT; CLOSTRIDIUM DIFFICILE; CONTROLLED STUDY; HEAT TOLERANCE; IMMUNOFLUORESCENCE; INTERNALIZATION; MACROPHAGE; MICROBIAL ADHESION; MOLECULAR WEIGHT; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN GLYCOSYLATION; SGTA GENE; SURFACE PROPERTY; TANDEM MASS SPECTROMETRY; WESTERN BLOTTING; WILD TYPE;

AMINO ACID SEQUENCE; ANIMALS; BACTERIAL ADHESION; CLOSTRIDIUM DIFFICILE; COMPUTATIONAL BIOLOGY; GENE EXPRESSION REGULATION, BACTERIAL; MACROPHAGES; MEMBRANE GLYCOPROTEINS; MICE; MOLECULAR SEQUENCE DATA; SPORES, BACTERIAL;

EID: 84903384902     PISSN: 00219193     EISSN: 10985530     Source Type: Journal    
DOI: 10.1128/JB.01469-14     Document Type: Article

References (47)

1. Rupnik M, Wilcox MH, Gerding DN. 2009. Clostridium difficile infection: new developments in epidemiology and pathogenesis. Nat. Rev. Microbiol. 7:526-536.
2. Freeman J, Bauer MP, Baines SD, Corver J, Fawley WN, Goorhuis B, Kuijper EJ, Wilcox MH. 2010. The changing epidemiology of Clostridium difficile infections. Clin. Microbiol. Rev. 23:529-549.
3. Ananthakrishnan AN. 2011. Clostridium difficile infection: epidemiology, risk factors and management. Nat. Rev. Gastroenterol. Hepatol. 8:17-26.
4. Gerding DN, Muto CA, Owens RC, Jr. 2008. Measures to control and prevent Clostridium difficile infection. Clin. Infect. Dis. 46(Suppl 1):S43-S49.
5. Lawley TD, Clare S, Walker AW, Goulding D, Stabler RA, Croucher N, Mastroeni P, Scott P, Raisen C, Mottram L, Fairweather NF, Wren BW, Parkhill J, Dougan G. 2009. Antibiotic treatment of clostridium difficile carrier mice triggers a supershedder state, spore-mediated transmission, and severe disease in immunocompromised hosts. Infect. Immun. 77: 3661-3669.
6. Lawley TD, Croucher NJ, Yu L, Clare S, Sebaihia M, Goulding D, Pickard DJ, Parkhill J, Choudhary J, Dougan G. 2009. Proteomic and genomic characterization of highly infectious Clostridium difficile 630 spores. J. Bacteriol. 191:5377-5386.
7. Permpoonpattana P, Phetcharaburanin J, Mikelsone A, Dembek M, Tan S, Brisson MC, La Ragione R, Brisson AR, Fairweather N, Hong HA, Cutting SM. 2013. Functional characterization of Clostridium difficile spore coat proteins. J. Bacteriol. 195:1492-1503.
8. Permpoonpattana P, Tolls EH, Nadem R, Tan S, Brisson A, Cutting SM. 2011. Surface layers of Clostridium difficile endospores. J. Bacteriol. 193:6461-6470.
9. Paredes-Sabja D, Bond C, Carman RJ, Setlow P, Sarker MR. 2008. Germination of spores of Clostridium difficile strains, including isolates from a hospital outbreak of Clostridium difficile-associated disease (CDAD). Microbiology 154:2241-2250.
10. Burns DA, Heap JT, Minton NP. 2010. SleC is essential for germination of Clostridium difficile spores in nutrient-rich medium supplemented with the bile salt taurocholate. J. Bacteriol. 192:657-664.
11. Burns DA, Heeg D, Cartman ST, Minton NP. 2011. Reconsidering the sporulation characteristics of hypervirulent Clostridium difficile BI/ NAP1/027. PLoS One 6:e24894.
12. Abhyankar W, Hossain AH, Djajasaputra A, Permpoonpattana P, Ter Beek A, Dekker HL, Cutting SM, Brul S, de Koning LJ, de Koster CG. 2013. In pursuit of protein targets: proteomic characterization of bacterial spore outer layers. J. Proteome Res. 12:4507-4521.
13. Charlton S, Moir AJ, Baillie L, Moir A. 1999. Characterization of the exosporium of Bacillus cereus. J. Appl. Microbiol. 87:241-245.
14. Redmond C, Baillie LW, Hibbs S, Moir AJ, Moir A. 2004. Identification of proteins in the exosporium of Bacillus anthracis. Microbiology 150: 355-363.
15. Sylvestre P, Couture-Tosi E, Mock M. 2002. Acollagen-like surface glycoprotein is a structural component of the Bacillus anthracis exosporium. Mol. Microbiol. 45:169-178.
16. Daubenspeck JM, Zeng H, Chen P, Dong S, Steichen CT, Krishna NR, Pritchard DG, Turnbough CL, Jr. 2004. Novel oligosaccharide side chains of the collagen-like region of BclA, the major glycoprotein of the Bacillus anthracis exosporium. J. Biol. Chem. 279:30945-30953.
17. Steichen C, Chen P, Kearney JF, Turnbough CL, Jr. 2003. Identification of the immunodominant protein and other proteins of the Bacillus anthracis exosporium. J. Bacteriol. 185:1903-1910.
18. Waller LN, Stump MJ, Fox KF, Harley WM, Fox A, Stewart GC, Shahgholi M. 2005. Identification of a second collagen-like glycoprotein produced by Bacillus anthracis and demonstration of associated sporespecific sugars. J. Bacteriol. 187:4592-4597.
19. Tamborrini M, Holzer M, Seeberger PH, Schurch N, Pluschke G. 2010. Anthrax spore detection by a Luminex assay based on monoclonal antibodies that recognize anthrose-containing oligosaccharides. Clin. Vaccine Immunol. 17:1446-1451.
20. Dong S, McPherson SA, Tan L, Chesnokova ON, Turnbough CL, Jr, Pritchard DG. 2008. Anthrose biosynthetic operon of Bacillus anthracis. J. Bacteriol. 190:2350-2359.
21. Mehta AS, Saile E, Zhong W, Buskas T, Carlson R, Kannenberg E, Reed Y, Quinn CP, Boons GJ. 2006. Synthesis and antigenic analysis of the BclA glycoprotein oligosaccharide from the Bacillus anthracis exosporium. Chemistry 12:9136-9149.
22. Blum H, Beier H, Gross HJ. 1987. Improved silver staining of plant proteins, RNA and DNA in polyacrylamide gels. Electrophoresis 8:93-99.
23. Gharahdaghi F, Weinberg CR, Meagher DA, Imai BS, Mische SM. 1999. Mass spectrometric identification of proteins from silver-stained polyacrylamide gel: a method for the removal of silver ions to enhance sensitivity. Electrophoresis 20:601-605.
24. Fulton KM, Zhao X, Petit MD, Kilmury SL, Wolfraim LA, House RV, Sjostedt A, Twine SM. 2011. Immunoproteomic analysis of the human antibody response to natural tularemia infection with type A or type B strains or LVS vaccination. Int. J. Med. Microbiol. 301:591-601.
25. Heap JT, Cartman ST, Kuehne SA, Cooksley C, Minton NP. 2010. ClosTron-targeted mutagenesis. Methods Mol. Biol. 646:165-182.
26. Heap JT, Kuehne SA, Ehsaan M, Cartman ST, Cooksley CM, Scott JC, Minton NP. 2010. The ClosTron: mutagenesis in Clostridium refined and streamlined. J. Microbiol. Methods 80:49-55.
27. Fagan RP, Fairweather NF. 2011. Clostridium difficile has two parallel and essential Sec secretion systems. J. Biol. Chem. 286:27483-27493.
28. Aubry A, Hussack G, Chen W, KuoLee R, Twine SM, Fulton KM, Foote S, Carrillo CD, Tanha J, Logan SM. 2012. Modulation of toxin production by the flagellar regulon in Clostridium difficile. Infect. Immun. 80: 3521-3532.
29. Todd SJ, Moir AJ, Johnson MJ, Moir A. 2003. Genes of Bacillus cereus and Bacillus anthracis encoding proteins of the exosporium. J. Bacteriol. 185:3373-3378.
30. Escobar-Cortes K, Barra-Carrasco J, Paredes-Sabja D. 2013. Proteases and sonication specifically remove the exosporium layer of spores of Clostridium difficile strain 630. J. Microbiol. Methods 93:25-31.
31. Paredes-Sabja D, Cofre-Araneda G, Brito-Silva C, Pizarro-Guajardo M, Sarker MR. 2012. Clostridium difficile spore-macrophage interactions: spore survival. PLoS One 7:e43635.
32. Barra-Carrasco J, Olguin-Araneda V, Plaza-Garrido A, Miranda-Cardenas C, Cofre-Araneda G, Pizarro-Guajardo M, Sarker MR, Paredes-Sabja D. 2013. The Clostridium difficile exosporium cysteine (CdeC)-rich protein is required for exosporium morphogenesis and coat assembly. J. Bacteriol. 195: 3863-3875.
33. Schirm M, Kalmokoff M, Aubry A, Thibault P, Sandoz M, Logan SM. 2004. Flagellin from Listeria monocytogenes is glycosylated with beta-Olinked N-acetylglucosamine. J. Bacteriol. 186:6721-6727.
34. Fimlaid KA, Bond JP, Schutz KC, Putnam EE, Leung JM, Lawley TD, Shen A. 2013. Global analysis of the sporulation pathway of Clostridium difficile. PLoS Genet. 9:e1003660.
35. Saujet L, Pereira FC, Serrano M, Soutourina O, Monot M, Shelyakin PV, Gelfand MS, Dupuy B, Henriques AO, Martin-Verstraete I. 2013. Genome-wide analysis of cell type-specific gene transcription during spore formation in Clostridium difficile. PLoS Genet. 9:e1003756.
36. Szymanski CM, Burr DH, Guerry P. 2002. Campylobacter protein glycosylation affects host cell interactions. Infect. Immun. 70:2242-2244.
37. Scott AE, Twine SM, Fulton KM, Titball RW, Essex-Lopresti AE, Atkins TP, Prior JL. 2011. Flagellar glycosylation in Burkholderia pseudomallei and Burkholderia thailandensis. J. Bacteriol. 193:3577-3587.
38. Fletcher CM, Coyne MJ, Villa OF, Chatzidaki-Livanis M, Comstock LE. 2009. A general O-glycosylation system important to the physiology of a major human intestinal symbiont. Cell 137:321-331.
39. Lindenthal C, Elsinghorst EA. 1999. Identification of a glycoprotein produced by enterotoxigenic Escherichia coli. Infect. Immun. 67:4084-4091.
40. Benz I, Schmidt MA. 2001. Glycosylation with heptose residues mediated by the aah gene product is essential for adherence of the AIDA-I adhesin. Mol. Microbiol. 40:1403-1413.
41. Paredes-Sabja D, Sarker MR. 2012. Adherence of Clostridium difficile spores to Caco-2 cells in culture. J. Med. Microbiol. 61:1208-1218.
42. Basu S, Kang TJ, Chen WH, Fenton MJ, Baillie L, Hibbs S, Cross AS. 2007. Role of Bacillus anthracis spore structures in macrophage cytokine responses. Infect. Immun. 75:2351-2358.
43. Pizarro-Guajardo M, Olguin-Araneda V, Barra-Carrasco J, Brito-Silva C, Sarker MR, Paredes-Sabja D. 2013. Characterization of the collagenlike exosporium protein, BclA1, of Clostridium difficile spores. Anaerobe 25:18-30.
44. Hussain HA, Roberts AP, Mullany P. 2005. Generation of an erythromycin-sensitive derivative of Clostridium difficile strain 630 (630Deltaerm) and demonstration that the conjugative transposon Tn916DeltaE enters the genome of this strain at multiple sites. J. Med. Microbiol. 54: 137-141.
45. Stabler RA, He M, Dawson L, Martin M, Valiente E, Corton C, Lawley TD, Sebaihia M, Quail MA, Rose G, Gerding DN, Gibert M, Popoff MR, Parkhill J, Dougan G, Wren BW. 2009. Comparative genome and phenotypic analysis of Clostridium difficile 027 strains provides insight into the evolution of a hypervirulent bacterium. Genome Biol. 10:R102.
46. Forgetta V, Oughton MT, Marquis P, Brukner I, Blanchette R, Haub K, Magrini V, Mardis ER, Gerding DN, Loo VG, Miller MA, Mulvey MR, Rupnik M, Dascal A, Dewar K. 2011. Fourteen-genome comparison identifies DNA markers for severe-disease-associated strains of Clostridium difficile. J. Clin. Microbiol. 49:2230-2238.
47. He M, Sebaihia M, Lawley TD, Stabler RA, Dawson LF, Martin MJ, Holt KE, Seth-Smith HM, Quail MA, Rance R, Brooks K, Churcher C, Harris D, Bentley SD, Burrows C, Clark L, Corton C, Murray V, Rose G, Thurston S, van Tonder A, Walker D, Wren BW, Dougan G, Parkhill J. 2010. Evolutionary dynamics of Clostridium difficile over short and long time scales. Proc. Natl. Acad. Sci. U.S.A. 107:7527-7532.